PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18271020-0	2008	Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells.	Prednisone	0-10	CD34 molecule	Homo sapiens	59-63	
35392613-5	2022	Results: The model was as follows: Y = 0.0322 x (age) - 0.0696 x (gender) + 0.5492 x (underlying disease) + 0.0963 x (the cumulative dose of prednisone during pre-engraftment phase) - 0.0771 x (CD34+ cell counts in graft) - 1.2926.	Prednisone	141-151	CD34 molecule	Homo sapiens	194-198	
19573409-12	2009	TdT/CD10/CD34/CD19 was expressed more in MLL-AF4 negative group (P = 0.005) and Prednisone Good Response group (P = 0.002).	Prednisone	80-90	CD34 molecule	Homo sapiens	9-13	
19899124-1	2009	The yield of CD34+ cells collected by apheresis for autologous peripheral blood stem cell (PBSC) transplantation was greatly increased when the appropriate timing was determined to begin using G-CSF after COAEP (Cytoxan, Vinblastine, Arabinosylcytosin, Etoposide and Prednisone) mobilization.	Prednisone	267-277	CD34 molecule	Homo sapiens	13-17	
18271020-4	2008	RESULTS: Leukemia samples that sustained the treatment in vitro with prednisone, showed significative reduction of CD10 and CD34 expression compared with control, and it was comparable with that observed in residual leukemic cells of the same patients in BM at day 15 of treatment.	Prednisone	69-79	CD34 molecule	Homo sapiens	124-128	
9796853-7	1998	She was transplanted with autologous mobilized CD34+ SC and progenitor cells after conditioning with cyclosphosphamide, anti-T lymphocyte globulin and prednisone.	Prednisone	151-161	CD34 molecule	Homo sapiens	47-51